Skip to main content
Top

15-05-2018 | Diet | Article

Glycemic impact of non-nutritive sweeteners: a systematic review and meta-analysis of randomized controlled trials

Journal: European Journal of Clinical Nutrition

Authors: Alexander D. Nichol, Maxwell J. Holle, Ruopeng An

Publisher: Nature Publishing Group UK

Abstract

Background/objectives

Nonnutritive sweeteners (NNSs) are zero- or low-calorie alternatives to nutritive sweeteners, such as table sugars. A systematic review and meta-analysis of randomized controlled trials was conducted to quantitatively synthesize existing scientific evidence on the glycemic impact of NNSs.

Subjects/methods

PubMed and Web of Science databases were searched. Two authors screened the titles and abstracts of candidate publications. The third author was consulted to resolve discrepancies. Twenty-nine randomized controlled trials, with a total of 741 participants, were included and their quality assessed. NNSs under examination included aspartame, saccharin, steviosides, and sucralose. The review followed the PRISMA guidelines.

Results

Meta-analysis was performed to estimate and track the trajectory of blood glucose concentrations over time after NNS consumption, and to test differential effects by type of NNS and participants’ age, weight, and disease status. In comparison with the baseline, NNS consumption was not found to increase blood glucose level, and its concentration gradually declined over the course of observation following NNS consumption. The glycemic impact of NNS consumption did not differ by type of NNS but to some extent varied by participants’ age, body weight, and diabetic status.

Conclusions

NNS consumption was not found to elevate blood glucose level. Future studies are warranted to assess the health implications of frequent and chronic NNS consumption and elucidate the underlying biological mechanisms.
Literature
1.
An R. Health care expenses in relation to obesity and smoking among US adults by gender, race/ethnicity, and age group: 1998–2011. Public Health. 2015;129:29–36.CrossRef
2.
Fryar CD, Carroll MD, Ogden C. Prevalence of overweight and obesity among children and adolescents aged 2–19 years: United States, 1963–1965 through 2013–2014, 2016, [Available from: https://​www.​cdc.​gov/​nchs/​data/​hestat/​obesity_​child_​13_​14/​obesity_​child_​13_​14.​pdf].
3.
Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev. 2011;12:50–61.CrossRef
4.
NCD Risk Factor Collaboration. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants. Lancet. 2016;387:1377–96.
5.
Malik VS, Popkin BM, Bray GA, Després J-P, Hu FB. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation. 2010;121:1356–64.CrossRef
6.
Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2013;346:e7492.CrossRef
7.
Dennis EA, Flack KD, Davy BM. Beverage consumption and adult weight management: a review. Eat Behav. 2009;10:237–46.CrossRef
8.
WHO. Population nutrient intake goals for preventing diet-related chronic diseases: World Health Organization Available from: http://​www.​who.​int/​nutrition/​topics/​5_​Population_​Nutrient/​EN/​
9.
Department of Health, US. Dietary guidelines for Americans 2015-2020. New York City, N.Y.: Skyhorse Publishing Inc.; 2017.
10.
WHO. Guideline: sugars intake for adults and children. Geneva: World Health Organization; 2015.
11.
Sylvetsky AC, Jin Y, Clark EJ, Welsh JA, Rother KI, Talegawkar SA. Consumption of low-calorie sweeteners among children and adults in the United States. J Acad Nutr Diet. 2017;117:441–8. e2.CrossRef
12.
Food and Drug Administration, US. Additional information about high-intensity sweeteners permitted for use in food in the United States 2015 [updated 05/26/2015].
13.
Whitehouse CR, Boullata J, McCauley LA. The potential toxicity of artificial sweeteners. Aaohn J. 2008;56:251–61.CrossRef
14.
Food and Drug Administration, US. High-intensity sweeteners 2014. Available from: https://​www.​fda.​gov/​food/​ingredientspacka​ginglabeling/​foodadditivesing​redients/​ucm397716.​htm.
15.
Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, et al. Nonnutritive sweeteners: current use and health perspectives. Circulation. 2012;126:509–19.CrossRef
16.
Shankar P, Ahuja S, Sriram K. Non-nutritive sweeteners: review and update. Nutrition. 2013;29:1293–9.CrossRef
17.
Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37:S120–S43.CrossRef
18.
Pepino MY. Metabolic effects of non-nutritive sweeteners. Physiol Behav. 2015;152:450–5.CrossRef
19.
Romo-Romo A, Aguilar-Salinas CA, Brito-Córdova GX, Díaz RAG, Valentín DV, Almeda-Valdes P. Effects of the non-nutritive sweeteners on glucose metabolism and appetite regulating hormones: systematic review of observational prospective studies and clinical trials. PLoS ONE. 2016;11:e0161264.CrossRef
20.
Berlin I, Vorspan F, Warot D, Manéglier B, Spreux-Varoquaux O. Effect of glucose on tobacco craving. Is it mediated by tryptophan and serotonin? Psychopharmacology. 2005;178:27–34.CrossRef
21.
Brandt KR, Gibson EL, Rackie JM. Differential facilitative effects of glucose administration on Stroop task conditions. Behav Neurosci. 2013;127:932.CrossRef
22.
Brandt KR, Sünram-Lea SI, Qualtrough K. The effect of glucose administration on the emotional enhancement effect in recognition memory. Biol Psychol. 2006;73:199–208.CrossRef
23.
Brown AW, Brown MMB, Onken KL, Beitz DC. Short-term consumption of sucralose, a nonnutritive sweetener, is similar to water with regard to select markers of hunger signaling and short-term glucose homeostasis in women. Nutr Res. 2011;31:882–8.CrossRef
24.
Burns TS, Stargel W, Tschanz C, Kotsonis FN, Hurwitz A. Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino acid ratio in healthy subjects. Pharmacology. 1991;43:210–9.CrossRef
25.
Coppola L, Coppola A, Grassia A, Mastrolorenzo L, Lettieri B, De Lucia D, et al. Acute hyperglycemia alters von Willebrand factor but not the fibrinolytic system in elderly subjects with normal or impaired glucose tolerance. Blood Coagul & Fibrinolysis. 2004;15:629–35.CrossRef
26.
Flint RW, Turek C. Glucose effects on a continuous performance test of attention in adults. Behav Brain Res. 2003;142:217–28.CrossRef
27.
Foster J, Lidder P, Sünram S. Glucose and memory: fractionation of enhancement effects? Psychopharmacol (Berl). 1998;137:259–70.CrossRef
28.
Geuns JM, Buyse J, Vankeirsbilck A, Temme EH. Metabolism of stevioside by healthy subjects. Exp Biol Med. 2007;232:164–73.
29.
Gonder-Frederick L, Hall J, Vogt J, Cox D, Green J, Gold P. Memory enhancement in elderly humans: effects of glucose ingestion. Physiol Behav. 1987;41:503–4.CrossRef
30.
Green MW, Taylor MA, Elliman NA, Rhodes O. Placebo expectancy effects in the relationship between glucose and cognition. Br J Nutr. 2001;86:173–9.CrossRef
31.
Hazali N, Mohamed A, Ibrahim M, Masri M, Isa KAM, Nor NM. Effect of acute Stevia consumption on blood glucose response in healthy Malay young adults. Sains Malays. 2014;43:649–54.
32.
Horwitz DL, McLane M, Kobe P. Response to single dose of aspartame or saccharin by NIDDM patients. Diabetes Care. 1988;11:230–4.CrossRef
33.
Just T, Pau HW, Engel U, Hummel T. Cephalic phase insulin release in healthy humans after taste stimulation? Appetite. 2008;51:622–7.CrossRef
34.
Manning CA, Parsons MW, Gold PE. Anterograde and retrograde enhancement of 24-h memory by glucose in elderly humans. Behav Neural Biol. 1992;58:125–30.CrossRef
35.
Manning CA, Stone WS, Korol DL, Gold PE. Glucose enhancement of 24-h memory retrieval in healthy elderly humans. Behav Brain Res. 1998;93:71–6.CrossRef
36.
Messier C, Desrochers A, Gagnon M. Effect of glucose, glucose regulation, and word imagery value on human memory. Behav Neurosci. 1999;113:431.CrossRef
37.
Messier C, Gagnon M, Knott V. Effect of glucose and peripheral glucose regulation on memory in the elderly. Neurobiol Aging. 1997;18:297–304.CrossRef
38.
Newcomer JW, Craft S, Fucetola R, Moldin SO, Selke G, Paras L, et al. Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr Bull. 1999;25:321–35.CrossRef
39.
Nguyen UN, Dumoulin G, Henriet M-Trs, Regnard J. Aspartame ingestion increases urinary calcium, but not oxalate excretion, in healthy subjects. J Clin Endocrinol & Metab. 1998;83:165–8.CrossRef
40.
Okuno G, Kawakami F, Tako H, Kashihara T, Shibamoto S, Yamazaki T, et al. Glucose tolerance, blood lipid, insulin and glucagon concentration after single or continuous administration of aspartame in diabetics. Diabetes Res Clin Pract. 1986;2:23–7.CrossRef
41.
Parent MB, Krebs-Kraft DL, Ryan JP, Wilson JS, Harenski C, Hamann S. Glucose administration enhances fMRI brain activation and connectivity related to episodic memory encoding for neutral and emotional stimuli. Neuropsychologia. 2011;49:1052–66.CrossRef
42.
Shigeta H, Yoshida T, Nakai M, Mori H, Kano Y, Nishioka H, et al. Effects of aspartame on diabetic rats and diabetic patients. J Nutr Sci Vitaminol (Tokyo). 1985;31:533–40.CrossRef
43.
Smeets PA, de Graaf C, Stafleu A, van Osch MJ, van der Grond J. Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr. 2005;82:1011–6.CrossRef
44.
Tey S, Salleh N, Henry J, Forde C. Effects of aspartame-, monk fruit-, stevia-and sucrose-sweetened beverages on postprandial glucose, insulin and energy intake. Int J Obes. 2017;41:450–7.CrossRef
45.
Wu T, Bound MJ, Zhao BR, Standfield SD, Bellon M, Jones KL, et al. Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes. Diabetes Care. 2013;36:1913–8.CrossRef
46.
Wu T, Zhao BR, Bound MJ, Checklin HL, Bellon M, Little TJ, et al. Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans. Am J Clin Nutr. 2012;95:78–83.CrossRef
47.
Walk AM, Raine LB, Kramer AF, Cohen NJ, Khan NA, Hillman CH. Differential effects of carbohydrates on behavioral and neuroelectric indices of selective attention in preadolescent children. Front Hum Neurosci. 2017;11:614.CrossRef
48.
Ginieis R, Franz EA, Oey I, Peng M. The “sweet” effect: comparative assessments of dietary sugars on cognitive performance. Physiol Behav. 2018;184:242–7.CrossRef
49.
Raben A, Richelsen B. Artificial sweeteners: a place in the field of functional foods? Focus on obesity and related metabolic disorders. Curr Opin Clin Nutr Metab Care. 2012;15:597–604.CrossRef
50.
Moebus S, Göres L, Lösch C, Jöckel K-H. Impact of time since last caloric intake on blood glucose levels. Eur J Epidemiol. 2011;26:719.CrossRef
51.
DECODE Study Group. Age-and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61–9.CrossRef
52.
Bakari AG, Onyemelukwe GC, Sani BG, Aliyu IS, Hassan SS, Aliyu TM. Relationship between random blood sugar and body mass index in an African population. Int J Diabetes Metab. 2006;14:144.CrossRef
53.
Kalyani RR, Egan JM. Diabetes and altered glucose metabolism with aging. Endocrinol Metab Clinics. 2013;42:333–47.CrossRef
54.
Brown RJ, Rother KI. Non-nutritive sweeteners and their role in the gastrointestinal tract. J Clin Endocrinol Metab. 2012;97:2597–605.CrossRef
55.
W-n Cong, Wang R, Cai H, Daimon CM, Scheibye-Knudsen M, Bohr VA, et al. Long-term artificial sweetener acesulfame potassium treatment alters neurometabolic functions in C57BL/6J mice. PLoS ONE. 2013;8:e70257.CrossRef
56.
Filer L, Stegink LD. Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects. Diabetes Care. 1989;12:67–74.CrossRef
57.
Koyama E, Sakai N, Ohori Y, Kitazawa K, Izawa O, Kakegawa K, et al. Absorption and metabolism of glycosidic sweeteners of stevia mixture and their aglycone, steviol, in rats and humans. Food Chem Toxicol. 2003;41:875–83.CrossRef
58.
McChesney E, Golberg L. The excretion and metabolism of saccharin in man. I. Methods of investigation and preliminary results. Food Cosmet Toxicol. 1973;11:403–14.CrossRef
59.
Murata Y, Ogawa T, Suzuki YA, Yoshikawa S, Inui H, Sugiura M, et al. Digestion and absorption of Siraitia grosvenori triterpenoids in the rat. Biosci Biotechnol Biochem. 2010;74:673–6.CrossRef
60.
Nofre C, Tinti J-M. Neotame: discovery, properties, utility. Food Chem. 2000;69:245–57.CrossRef
61.
Schiffman SS, Rother KI. Sucralose, a synthetic organochlorine sweetener: overview of biological issues. J Toxicol Environ Health, Part B. 2013;16:399–451.CrossRef
62.
Swithers SE. Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends Endocrinol Metab. 2013;24:431–41.CrossRef
63.
Azad MB, Abou-Setta AM, Chauhan BF, Rabbani R, Lys J, Copstein L, et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials and prospective cohort studies. Can Med Assoc J. 2017;189:E929–E39.CrossRef
64.
Rini GB, Di Fede G, Mascellino MR, Rizzo G. The effect of artificial sweetener on insulin secretion. 1. The effect of acesulfame K on insulin secretion in the rat (studies in vivo). Boll Soc Ital Biol Sper. 1987;63:509–13.PubMed
65.
Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Physiol Behav. 2009;98:618–24. https://​doi.​org/​10.​1016/​j.​physbeh.​2009.​09.​016.CrossRef
66.
Fukuda M, Terata T, Tsuda K, Sugawara M, Kitatani N, Seino Y. Aspartame-acesulfame K-containing low-energy erythritol sweetener markedly suppresses postprandial hyperglycemia in mild and borderline diabetics. Food Sci Technol Res. 2010;16:457–66.CrossRef
67.
Wang X-T, Dvorak RD. Sweet future: fluctuating blood glucose levels affect future discounting. Psychol Sci. 2010;21:183–8.CrossRef
68.
Steinert RE, Frey F, Töpfer A, Drewe J, Beglinger C. Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides. Br J Nutr. 2011;105:1320–8.CrossRef
69.
Brown RJ, Walter M, Rother KI. Effects of diet soda on gut hormones in youths with diabetes. Diabetes Care. 2012;35:959–64.CrossRef
70.
Aaroe L, Petersen MB. Hunger games: fluctuations in blood glucose levels influence support for social welfare. Psychol Sci. 2013;24:2550–6.CrossRef
71.
Panahi S, El Khoury D, Luhovyy BL, Goff HD, Anderson GH. Caloric beverages consumed freely at meal-time add calories to an ad libitum meal. Appetite. 2013;65:75–82.CrossRef
72.
Otero-Losada ME, Mc Loughlin S, Rodriguez-Granillo G, Muller A, Ottaviano G, Moriondo M, et al. Metabolic disturbances and worsening of atherosclerotic lesions in ApoE-/- mice after cola beverages drinking. Cardiovasc Diabetol. 2013;12:57.CrossRef
73.
Wu TZ, Bound MJ, Standfield SD, Bellon M, Young RL, Jones KL, et al. Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans. Diabetes Care. 2013;36:E202–E3.CrossRef
74.
Bryant CE, Wasse LK, Astbury N, Nandra G, McLaughlin JT. Non-nutritive sweeteners: no class effect on the glycaemic or appetite responses to ingested glucose. Eur J Clin Nutr. 2014;68:629.CrossRef
75.
Yang Q. Gain weight by “going diet?” Artificial sweeteners and the neurobiology of sugar cravings: neuroscience 2010. Yale J Biol Med. 2010;83:101.PubMedPubMedCentral

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »